Skip to search formSkip to main contentSkip to account menu

inostamycin

Known as: Lysocellin, 20-de(1-hydroxypropyl)-6-demethyl-2,6-diethyl-5-hydroxy-20-(1-hydroxybutyl)-, (2S,4S,5R)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been considered as a possible therapeutic agent for cancer… 
Review
2010
Review
2010
Head and neck squamous cell carcinoma is the sixth most common type of neoplasm worldwide, but its prognosis has not improved… 
2005
2005
[reaction: see text] An approach to the C10-C24 ketone fragment of the inostamycin family of polyether antibiotics is described… 
2005
2005
Angiogenesis involves multiple steps including proliferation and migration of endothelial cells. In the present study, we… 
1998
1998
Previously, we demonstrated that inostamycin, an inhibitor of phosphatidylinositol turnover, caused cell cycle arrest at the G1… 
1998
1998
In the present study, we found that inostamycin increased the ability of paclitaxel to induce apoptosis in Ms‐1 cells. A… 
1994
1994
The addition of serum to quiescent normal rat kidney (NRK) cells induced phosphatidylinositol (PI) synthesis after 4 h and DNA… 
1991
1991
Inostamycin, a novel polyether compound, reverses multidrug resistance in KB cells. The mechanism of its action was studied by…